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Nonsense-mediated decay (NMD) is a translation-dependent RNA quality control mechanism 
that occurs in the cytoplasm. However, it is unknown how NMD regulates the stability of RNAs 
translated at the Endoplasmic Reticulum (ER). Here, we identify a localized NMD pathway 
dedicated to ER-translated mRNAs. We previously identified NBAS, a component of the 
Syntaxin 18 complex involved in Golgi-to-ER trafficking, as a novel NMD factor. Here, we show 
that NBAS fulfils an independent function in NMD. This ER-NMD pathway requires the 
interaction of NBAS with the core NMD factor UPF1, which is partially localized at the ER in 
the proximity of the translocon. NBAS and UPF1 co-regulate the stability of ER-associated 
transcripts, in particular those associated with the cellular stress response. We propose a model 
where NBAS recruits UPF1 to the membrane of the ER and activates an ER-dedicated NMD 
pathway, thus providing an ER protective function by ensuring quality control of ER-
translated mRNAs. 
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The nonsense-mediated decay (NMD) pathway is a highly conserved surveillance mechanism that 
targets mRNAs harboring premature termination codons (PTCs) for degradation. In doing so, it 
prevents the accumulation of truncated proteins and modulates the phenotypic outcome of genetic 
disorders that arise due to the presence of PTCs (Bhuvanagiri et al. 2010). Importantly, NMD also 
controls the stability of a large number of endogenous RNAs and fine-tunes many physiological 
processes (reviewed by (Karousis and Mühlemann, 2019; Kurosaki et al., 2019)). 
 Core NMD factors were initially identified in genetic screens in C. elegans and in S. cerevisiae 
and were later shown to be involved in NMD in other species, including Arabidopsis, Drosophila and 
mammals. Human orthologs include SMG1, UPF1, UPF2, UPF3, SMG5, SMG6, and SMG7. 
Additional NMD factors have been identified using a variety of different experimental approaches, 
including interactome studies, RNAi screens in nematodes and CRISPR screens in mammalian cells 
(Alexandrov et al. 2017; Baird et al. 2018; Hug et al. 2016). Mechanistically, NMD is tightly linked 
to mRNA translation and is initiated by the recognition of a PTC by the surveillance (SURF) complex 
within which the RNA helicase UPF1, and its associated kinase, SMG1, bind to the ribosomal release 
factors eRF1 and eRF3 (Karousis and Mühlemann 2019). Subsequently, components of the SURF 
complex interact with the core NMD factors UPF2 and UPF3b, and with an exon junction complex 
(EJC) located downstream of the PTC, to form the decay-inducing complex (DECID) that triggers 
UPF1 phosphorylation by SMG1, and dissociation of eRF1 and eRF3 (Kashima et al. 2006; Singh et 
al. 2007). This leads to the recruitment of mRNA degradation factors that trigger RNA decay. 
Substrate selection for NMD occurs not only in an EJC-dependent manner, but alternatively via an 
EJC-independent mechanism, which targets transcripts harboring very long 3’UTRs (Kurosaki et al., 
2019; Metze et al., 2013).  
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  Using RNAi screens in C. elegans, we previously identified several novel NMD factors that were 
also essential for viability, suggesting that they fulfil additional functions in nematodes, where this 
pathway is not essential (Longman et al. 2007; Casadio et al. 2015). One of these novel NMD factors 
is encoded by smgl-1 that corresponds to the human gene NBAS (neuroblastoma amplified sequence, 
also known as NAG, for neuroblastoma amplified gene). NBAS was first identified as a gene that is 
co-amplified with the N-myc gene in human neuroblastomas, however no clear role in the disease has 
been reported (Wimmer et al. 1999; Scott et al. 2003). We previously showed that NBAS acts in 
concert with UPF1 to co-regulate a large number of transcripts not only in nematodes but also in 
zebrafish and human cells (Anastasaki et al. 2011; Longman et al. 2013). NBAS encodes a peripheral 
ER membrane protein that is a component of the Syntaxin 18 complex, which functions in Golgi-to-
ER retrograde transport (Aoki et al. 2009). A series of loss-of-function mutations in NBAS have been 
found in several human conditions, including biallelic mutations in patients with a multisystem 
disease involving liver, eye, immune system, connective tissue and bone (Haack et al. 2015; Segarra 
et al. 2015). Compound heterozygous variants in NBAS were also identified as a cause of atypical 
osteogenesis imperfecta (Balasubramanian et al. 2017) and in a short stature with optic atrophy and 
Pelger-Huët anomaly (SOPH) syndrome (Maksimova et al. 2010). Currently, it remains unclear 
whether the phenotypes observed in patients with mutations in NBAS, are due to a compromised NMD 
response, defects in Golgi-to-ER retrograde transport, or a combination of both. 
 Despite initial controversy concerning the intracellular location of NMD in mammalian cells, it 
has been conclusively demonstrated that decay of a PTC-containing β-globin NMD reporter occurs 
in the cytoplasm (Trcek et al. 2013). The ER is a major site of localized protein synthesis, with 
approximately a third of all mRNAs being translated there, in particular, those encoding proteins 
entering the secretory pathway. It has become increasingly evident that ER and cytosol constitute 
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different environment for protein translation and post-transcriptional gene regulation (Reid and 
Nicchitta 2015). Current efforts have focused on the mechanism and regulation of cytoplasmic NMD; 
however, it is largely unknown how this mechanism operates on mRNAs that are translated at the 
ER, which due to their intrinsic localized translation will not have sufficient exposure to cytoplasmic 
NMD. There is a precedent for a localized NMD response in neurons, where NMD regulates the 
expression of both dendritic and axonal mRNAs upon their activation of localized mRNA translation 
(Giorgi et al. 2007; Colak et al. 2013). Both NBAS and a second novel NMD factor identified in our 
RNAi screens, SEC13 (nuclear pore and COPII coat complex component), localize to the membrane 
of the ER, raising the possibility that they could be involved in an ER-localized NMD pathway 
(Longman et al. 2007; Casadio et al. 2015).  
 Here, we present evidence that reveals a central role for NBAS, acting together with UPF1, in an 
NMD response that is associated with the ER. We show that NBAS has dual roles in NMD and Golgi-
to-ER retrograde transport; but importantly, these functions act independent of each other. We 
demonstrate that NBAS recruits the core NMD factor UPF1 to the membrane of the ER and promotes 
the degradation of NMD substrates that are translated at the ER.  
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Results 
 
A dual role of NBAS in Golgi-to-ER transport and NMD 
NBAS encodes a 2,371 amino acid protein containing WD40 repeats and a SEC39 domain, present in 
proteins involved in the secretory pathway (Fig. 1A). Together with RINT1 and ZW10, NBAS forms 
part of the evolutionarily conserved NRZ complex, which functions as a tethering complex for 
retrograde trafficking of COPI vesicles from the Golgi to the ER and is part of the larger Syntaxin 18 
complex (Aoki et al. 2009; Civril et al. 2010).  
 To dissect whether NBAS had separate roles in NMD and Golgi-to-ER transport, or whether these 
processes influence each other, we first tested whether abrogating the NMD pathway influences ER 
trafficking. We used a modified flow cytometry-based assay that relies on the expression of an eGFP 
fluorescent reporter for measuring constitutive secretion. This assay is based on the property of 
mutant FKBP (FK506-binding protein) (F36M) to form large aggregates that when expressed in the 
ER cannot be secreted. However, upon incubation with an FKBP (F36M) ligand, D/D Solubilizer, 
these aggregates are solubilized leading to efficient secretion (Gordon et al., 2010). We used this 
reporter in combination with siRNA-mediated knock-down of individual NMD factors or of 
components of the Syntaxin 18 complex (Fig. 1B and Supplemental Fig. S1A). Fluorescence of clonal 
HeLa C1 cells stably expressing the eGFP reporter decreased upon addition of the ligand, D/D 
Solubilizer, to the level of control cells, as was previously observed (Gordon et al. 2010) 
(Supplemental Fig. S1A, left panel). As expected, siRNA-mediated knockdown of components of the 
Syntaxin 18 complex, including STX18, p31 and NBAS resulted in an increase of the remaining 
fluorescence, due to an interference with the secretion process (Fig. 1B). We observed some effect 
upon depletion of ZW10, but almost no effect with the knock-down of RINT1, perhaps reflecting a 
differential contribution of these components to the secretion process. Importantly, we observed that 
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a strong reduction in the levels of individual NMD factors did not interfere with secretion. This was 
the case for UPF1 and UPF2, but also for the RNA helicase DHX34, and for SEC13, another NMD 
factor that localizes to the ER (Fig. 1B and Supplemental Fig. S1A). From this experiment, we 
conclude that NMD activity is not required for ER secretion.  
 Next, we investigated whether interfering with constitutive secretion had any effect on the NMD 
pathway. For this, HeLa cells stably expressing a well characterized b-globin NMD reporter 
harboring a nonsense mutation at position 39 (HBB NS39) (Trecartin et al. 1981), or its wild-type 
(wt) HBB counterpart, were depleted of NMD factors (UPF2 or NBAS) or of secretion factors 
(STX18 or STX5) using specific siRNAs (Supplemental Fig. S1D). As expected, the level of HBB 
WT mRNA remained unchanged upon UPF1, NBAS, STX18 or STX5 depletion (Fig. 1C, right 
panel). By contrast, depletion of UPF2 or of NBAS resulted in an increased level of the HBB NS39 
NMD reporter mRNA, compared to mock depleted cells (Fig. 1C, left panel). Importantly, depletion 
of either STX18 or STX5 did not affect the level of b-globin NMD reporter mRNA (Fig. 1C), 
indicating that normal ER secretion is not required for NMD. These results were confirmed using a 
fluorescent NMD reporter (NMD+) that quantifies NMD activity at the single cell level. Cells 
carrying the NMD+ reporter were identified by the constitutive expression of red fluorescence, 
whereas NMD activity was determined by the mean green fluorescence, which is subject to NMD, in 
all red cells (Pereverzev et al. 2015). Here again, whereas knock-down of UPF2 and NBAS resulted 
in increased levels of the NMD reporter (measured by increased green fluorescence), depletion of 
STX18 or STX5 had no effect (Supplemental Fig. S1B). We extended these observations to show 
that NMD activity is not affected by blocking constitutive secretion with the use of Brefeldin A that 
inhibits Golgi-to-ER protein transport (Aridor et al. 1995) (Supplemental Fig. S1C). HeLa cells stably 
expressing either HBB WT or HBB NS39 were treated with Actinomycin D to block transcription in 
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the presence or absence of Brefeldin A. We observed that the stability of the HBB NS39 NMD 
reporter mRNA was not increased by blocking ER secretion (Fig. 1D). Altogether, these experiments 
show that NMD activity and ER secretion are not functionally linked, strongly suggesting that NBAS 
has two independent roles in Golgi-ER retrograde transport and in NMD. 
 
 NBAS regulates a subset of NMD targets specifically translated at the ER 
Previously, we conducted RNA profiling experiments that revealed a large proportion of NBAS 
mRNA targets are co-regulated by the core NMD factor UPF1, with a significant enrichment for 
genes involved in the cellular stress response (Longman et al. 2013). Here, we extended this analysis 
by RNA-sequencing to profile changes in mRNA abundance upon depletion of NBAS or UPF1. Both 
NBAS and UPF1 were the most significantly downregulated genes in the relevant samples (fold 
change -1.85, p<3.51x10-13 and fold change -3.28, p<1.14x10-148, respectively) (Supplemental Table 
S1). Depletion of UPF1 significantly affected the mRNAs of 4756 genes, with 2411 genes displaying 
an increased mRNA expression upon UPF1 knock-down. Depletion of NBAS increased the mRNA 
levels of 209 genes (Supplemental Table S1), consistent with the view that NBAS regulates a subset 
of the UPF1 targets. We observed a robust co-regulation of mRNAs when UPF1 or NBAS was 
depleted (Pearson’s correlation r=0.67, p<0.0001) (Fig. 2A), indicating that UPF1 and NBAS 
function in a common pathway. Gene ontology (GO) analysis of the mRNAs regulated by both NBAS 
and UPF1 revealed a strong enrichment for the secretome, which is preferentially translated at the ER 
translocon (Supplemental Table S2).  Interestingly, we found a significant increase in fold change in 
genes associated with the ER unfolded protein response (UPR) (GO: 0006986) when either NBAS or 
UPF1 was depleted (p < 0.05 and p < 0.001 respectively; Wilcoxon rank sum test), showing that the 
ER stress response is perturbed when the NMD response at the ER is not functional (Supplemental 
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Fig. S2). This supports our hypothesis that an ER-specific NMD pathway is essential for cellular 
homeostasis.  
 To further characterize genes regulated by NBAS and UPF1, we intersected targets regulated 
by either NBAS or UPF1 and also common targets, with three experimental datasets identifying 
genes localized and/or translated at the ER. APEX-seq, a method for RNA sequencing based on 
direct proximity labeling of RNA led to the identification of 1077 mRNAs localized at the ER 
(Fazal et al., 2019), cell fractionation followed by ribosome footprinting identified 486 mRNAs 
(Reid & Nicchitta, 2012), and proximity-specific ribosome profiling, based on ER membrane 
proximity labelling of ribosomes, identified  686 mRNAs translated at the ER (Jan et al., 2014). 
We found that NBAS targets are strongly enriched for experimentally validated ER genes (31.6%), 
as compared to 14.4% of UPF1 targets. Furthermore, 18.2% of NBAS targets were found in two 
or more of the datasets, as compared to only 6.3% of UPF1 targets. Considering NBAS and UPF1 
common targets, 37.9% of targets were found in at least one dataset, whilst 23.2% were found in 
two or more datasets (Fig. 2B). NBAS-regulated targets were strongly enriched for experimentally 
identified ER-localized genes (OR=6.07, p<0.001, Fisher's Exact test), whereas UPF1 targets were 
only modestly enriched (OR=2.44, p<0.001, Fisher's Exact test). Compared to UPF1 targets, we 
found that those targets which were also regulated by NBAS were 2.6-fold more likely than 
expected by chance to be found at the ER (p<0.001, Exact Binomial test), confirming that NBAS 
and UPF1 together regulate NMD targets specifically at the ER.  
 We next examined how NBAS depletion affected transcripts specifically at the ER compared to 
the cytoplasm, and how this differs from depletion of core NMD factors UPF1 and UPF2. We 
performed RNA-sequencing on cytoplasmic and membrane fractions of HeLa cells depleted for each 
factor or mock-depleted control cells, following subcellular fractionation. By comparing expression 
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of genes in each fraction in control samples we defined a group of “membrane-associated” genes, as 
those that in the control sample showed a two-fold higher expression in the membrane fraction 
(magenta points), whereas all other expressed genes were deemed “non-membrane” genes (Fig. 2C). 
We assessed the validity of cell fractionation by identifying genes in the previously described 
experimentally validated ER datasets in our data. As expected, we observed that the majority of genes 
present in two or more ER datasets were found in the membrane-associated set (OR = 66.94, 
p<0.0001, Fishers Exact test) (Supplemental Fig. S3A). Next, we analyzed changes in gene 
expression of ‘membrane-associated’ genes in the membrane fraction, and of ‘non-membrane’ genes 
in the cytoplasmic fraction, upon depletion of individual NMD factors (Fig. 2D, Supplemental Figs. 
S3B and S3C, Supplemental Table S3). Knock-down of UPF1 led to a robust increase in the 
abundance of mRNAs in both membrane and cytoplasmic fractions, whereas depletion of NBAS led 
to an upregulation of a higher percentage of membrane-associated genes than of non-membrane genes 
(5-fold increase, p<0.001, Exact Binomial test). In contrast, depletion of UPF2 led to preferential 
upregulation of ‘non-membrane’ genes in the cytoplasm (>2.5-fold, p<0.001, Exact Binomial test). 
Altogether, these results suggest that NBAS is a crucial component of an ER-NMD pathway that 
targets for degradation mRNAs that are translated at the ER, constituting a novel localized NMD 
response. 
 
Site of NMD for transcripts translated at the ER  
Single-molecule RNA Fluorescent in Situ Hybridization (smRNA FISH) was previously used to 
localize the NMD response of a β-globin NMD reporter to the cytoplasm (Trcek et al. 2013). Here, 
we have used smRNA FISH to spatially map the location of mRNA degradation of mRNAs that are 
translated at the ER and that we have also shown to be upregulated upon UPF1 and/or NBAS 
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depletion (Longman et al. 2013). We used a set of fluorescent probes that label the full-length of two 
endogenous mRNAs targeted by NMD, which are translated either in the cytoplasm or at the ER. We 
selected SETD4 (SET Domain Containing 4) mRNA, which encodes a lysine methyl transferase and 
is translated in the cytoplasm (Faria et al. 2013). As an example of an mRNA that is translated at the 
ER we selected FAP mRNA (also known as Seprase), which encodes Fibroblast Activation Protein 
alpha, a 170kDa membrane-bound gelatinase (Goldstein et al. 1997). First, we showed that levels of 
SETD4 mRNA were robustly increased upon knock-down of UPF1, whereas NBAS depletion had 
only a marginal stabilizing effect (Fig. 3A). In contrast, the ER-localized FAP mRNA was 
comparably upregulated upon knock-down of UPF1 and of NBAS (Fig. 3A). 
 RNA FISH of SETD4 mRNA in UPF1-depleted cells revealed a strong increase of uniformly 
distributed fluorescent signal throughout the cell, consistent with NMD taking place in the cytoplasm. 
As expected, depletion of NBAS led only to a slight upregulation of SETD4 mRNA (Fig. 3B). 
Importantly, RNA-FISH of the ER-translated FAP mRNA in both UPF1 and NBAS-depleted cells 
revealed a strong increase of the fluorescent signal that clustered to the perinuclear region of the cell 
(Fig. 3C, green signal). The RNA-FISH fluorescence overlapped with ER staining (Fig. 3C, right 
panels), thus spatially mapping the mRNA degradation of an NBAS NMD target to the ER. This is 
consistent with an NBAS-dependent NMD-mediated degradation occurring at the ER. In order to 
represent the differences in the distribution of the smRNA FISH signal within cells, we plotted the 
distance of the fluorescent FISH signal from the edge of the nucleus (defined by DAPI staining), for 
each experimental condition. This demonstrated that UPF1 depletion leads to the accumulation of 
SETD4 mRNA that is distributed widely within the cell, which is significantly different from the 
distribution pattern of the ER-associated FAP mRNA signal that clusters close to the nuclear 
periphery upon depletion of both NBAS and UPF1 (Fig. 3D). Finally, using smRNA FISH signal 
     Longman et al. 
 12 
counts we confirmed the increase of SETD4 and FAP transcripts in response to UPF1 and NBAS 
depletion (Supplemental Fig. S4). Altogether, these results provide strong evidence that NBAS has a 
role in NMD regulation of mRNAs translated at the ER.  
 
UPF1 is present at the ER 
The involvement of the ER-associated factor NBAS in the NMD response, together with its co-
regulation of RNA targets with UPF1, led us to probe whether UPF1 localizes to the ER and interacts 
with NBAS. It has been previously reported that UPF1 localizes to the cytoplasm both in yeast (Atkin 
et al. 1995) and human cells (Applequist et al., 1997;Serin et al., 2001). There is, however, evidence 
that UPF1 is also localized at the ER. First, UPF1 was found associated with cytoplasmic, but also 
with ER-bound polysomes (Jagannathan et al. 2014a). Moreover, a large-scale protein-protein 
interactome revealed that UPF1 interacts with components of the Syntaxin 18 complex; ZW10, p31 
and STX18, where NBAS also resides (Brannan et al. 2016; Aoki et al. 2009). First, we tagged 
endogenous NBAS with an eGFP/ 3xFLAG-tag at its N-terminus and following anti-GFP 
immunoprecipitation, we revealed the interacting proteins using Mass Spectrometry. This resulted in 
the identification of several components of the Syntaxin 18 complex as well as of SEC61A1, a 
component of the trimeric SEC61 complex at the ER translocon that interact with NBAS 
independently of the presence of RNA (Hartmann et al. 1994) (Supplemental Fig. S5A and 
Supplemental Table S4). We did not observe a robust enrichment of NMD factors despite having 
demonstrated these interactions by other experimental approaches (see below Fig. 5 and 
Supplemental Figs. S6 and S7). We hypothesize this is due to the more transient nature of interactions 
between NBAS and NMD factors compared to components of the Syntaxin 18 complex.  
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 Immunofluorescence analysis of HeLa cells transiently transfected with FLAG-UPF1 showed that 
UPF1 localizes to the cytoplasm, as previously suggested. However, upon incubation of HeLa cells 
with Digitonin, which permeabilizes the plasma membrane and consequently releases cytosolic 
components that are not anchored to cellular membranes, we observed a population of UPF1 that was 
resistant to Digitonin treatment and co-localized with the ER marker calnexin, indicating ER 
membrane association (Fig. 4A). We next used the Proximity Ligation Assay (PLA) to probe for 
interactions of UPF1 and NBAS, with SEC61B, a component of the SEC61 channel-forming 
translocon complex that is a central component of the protein translocation apparatus at the ER 
membrane. PLA has been extensively used to detect interactions of many cellular proteins, including 
the core NMD factors UPF1 and UPF2 (Tatsuno et al. 2016). We detected a robust PLA interaction 
between UPF1 and SEC61B in HeLa cells, indicating that UPF1 localizes at the site of mRNA 
translation at the ER (Fig. 4B). PLA analysis of the endogenously NBAS-tagged cell line revealed 
that NBAS is also co-localized with SEC61B (Supplemental Fig. S5B).  
 Altogether, these results show that both UPF1 and NBAS are present at the translocon, bringing 
them into close proximity with mRNAs being translated at the ER. Even though UPF1 is the core 
factor essential for NMD function, it is likely that other NMD factors will, at times, also partially 
localize to the ER. Previously, immunofluorescence was used to colocalize SMG6 and UPF3B with 
GRP78, a member of the heat shock protein 70 (HSP70) family that is present in the lumen of the ER 
(Sakaki et al. 2012). More recently, a large human interactome study identified UPF3B, in complex 
with UPF2 and UPF1, to be associated with SEC61A1 (Hein et al. 2015). To investigate whether 
other components of the NMD pathway with previously established cytoplasmic localization are also 
present at the ER, we probed for the co-localization of UPF2 with SEC61B. We observed a modest 
PLA signal indicating that a fraction of UPF2 is also associated with the translocon at the ER in HeLa 
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cells (Supplemental Fig. S5C). This modest co-localization of UPF2 with the ER is consistent with 
our previous observation that UPF2 plays only a minor role in the regulation of ER-translated mRNAs 
(Fig. 2D).  
 
NBAS interacts with UPF1 and preferentially associates with the SURF complex  
The presence of NBAS and UPF1 in proximity with the ER translocon, together with the co-
regulation of RNA targets by NBAS and UPF1 as part of the ER-NMD response strongly suggested 
an interaction of these two NMD factors. To investigate this, we first tested for the co-purification of 
NBAS with UPF1 by co-immunoprecipitation in HeLa cells, in the presence or absence of RNases. 
We found that FLAG-tagged UPF1 co-immunoprecipitated with co-transfected T7-NBAS 
(Supplemental Fig. S6A) and we also detected the interaction of endogenous UPF1 with FLAG-
tagged NBAS, even in the absence of RNA (Supplemental Fig. S6B). Since UPF1 phosphorylation 
is a later step in NMD activation it can be used as a diagnostic tool to infer the timing of recruitment 
of a particular protein to the NMD complex. We used two UPF1 mutants that resemble the 
hypophosphorylated state of UPF1 when present in the early surveillance (SURF) complex (C126S), 
or the hyperphosphorylated UPF1 present in the late decay-inducing (DECID) complex (K498A) 
(Weng et al. 1996; Kashima et al. 2006)). As previously observed, the C126S mutation blocks UPF1 
interaction with UPF2, yet it binds to T7-tagged NBAS, whereas the K498A UPF1 mutant displayed 
no NBAS binding (Supplemental Fig. S6C). This strongly suggests that NBAS is preferentially 
associated with the initial surveillance SURF complex, where UPF1 is hypophosphorylated. 
Interestingly, we previously observed similar results for the RNA helicase DHX34 (Hug and Cáceres 
2014), suggesting that most of the regulatory steps of the NMD pathway occur in the early stages of 
the NMD response. The observed biochemical interaction of NBAS with UPF1 was not RNA-
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dependent (Supplemental Fig. S6A, B). Nevertheless, we wanted to investigate the possibility that 
NBAS directly recruits NMD targets for degradation. We tested whether NBAS directly binds to 
mRNA using an mRNA capture assay, which relies on in-situ UV crosslinking, followed by affinity 
selection of mRNPs by oligo-dT cellulose  (Piñol-Roma and Dreyfuss 1992; Sanford et al. 2005). 
Affinity selection of mRNPs by oligo-dT cellulose showed that NBAS binds to mRNA (Supplemental 
Fig. S6D), opening the possibility that RNA-binding by NBAS contributes to selection of NMD 
targets at the ER. 
 Next, we probed for the interaction of endogenous NBAS with other core NMD factors. We 
detected an interaction of transiently expressed FLAG-tagged SMG5, SMG6, SMG7 and UPF1 with 
endogenous NBAS, even in the absence of RNA (Supplemental Fig. S7A). Additionally, we observed 
that endogenous NBAS can also be co-purified with full-length tagged RNA helicase DHX34, but 
not with a truncated DHX34 version lacking an essential OB-like domain (Supplemental Fig. S7B), 
which is required for helicase function (Melero et al. 2016). 
 We used Förster Resonance Energy Transfer (FRET) to probe the interaction of NBAS and UPF1 
in HeLa cells in culture. This approach is based on the transfer of energy from the excited state of a 
donor fluorophore to an adjacent acceptor fluorophore when the two molecules are in the correct 
orientation and less than 10nm apart. FRET was detected by a reduction in the amount of energy that 
the donor releases as fluorescence, measured by Fluorescence Lifetime Imaging Microscopy (FLIM) 
(Day et al. 2001; Ellis et al. 2008). Co-transfection of GFP-NBAS and mCherry-UPF1 in HeLa cells 
resulted in a reduction of the average donor fluorescence lifetime and an increase in the FRET 
efficiency, as compared to transfection of GFP-NBAS and mCherry (Fig. 5A). This experiment 
strongly suggests that NBAS and UPF1 interact directly. Next, we performed Fluorescence Cross-
Correlation Spectroscopy (FCCS) to probe the interaction of NBAS and UPF1 in HeLa cells 
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transiently expressing GFP-NBAS and mCherry-UPF1 or GFP-NBAS and mCherry, as a control. 
The cross-correlation signal is a direct indication of both molecules moving together, where a low 
amplitude of cross-correlation signal indicates that the labeled molecules diffuse separately, whereas 
high amplitude of cross-correlation signal is only achieved when both molecules are bound and 
diffuse together. The high cross-correlation signal observed in HeLa cells transiently expressing GFP-
NBAS and mCherry-UPF1 indicated that NBAS and UPF1 interact directly (Fig. 5B, black curve), 
in contrast to the low amplitude of cross-correlation signal observed in cells expressing GFP-NBAS 
with mCherry, as a negative control (Fig. 5B, grey curve). Finally, we confirmed the interaction of 
endogenous NBAS and UPF1 using PLA. We observed a prominent PLA signal using antibodies 
against endogenous UPF1 and NBAS proteins, which was absent in cells that do not express NBAS 
(NBAS KO) (Fig. 5C). These results robustly show that NBAS and UPF1 interact directly in situ.  
 
NBAS recruits UPF1 to the membrane of the ER 
To probe the functional consequences of the NBAS-UPF1 interaction in vivo we used Fluorescence 
Correlation Spectroscopy (FCS). This is a non-invasive method with single-molecule sensitivity that 
allows the analysis of the dynamic behavior of fluorescent molecules with high temporal resolution 
and at low, physiologically-relevant concentrations in live cells (Liu et al. 2015; Papadopoulos et al. 
2019). When the recorded fluorescence intensity fluctuations are caused by molecular movement, 
FCS measurements can be used to measure molecular mobility/diffusion rate of fluorescent molecules 
in a sub-femtoliter detection volume in live cells. Thus, free, fast diffusing molecular movement is 
reflected by autocorrelation curves that display decays in shorter characteristic times (Fig. 6A, green 
curve), whereas bound or slow diffusing molecules are characterized by autocorrelation curves with 
slower decay times (Fig. 6A, orange curve). We performed FCS measurements to derive the mobility 
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of transiently transfected mCherry-UPF1, or mCherry control at the ER, in the perinuclear region of 
the cell, or in the cytoplasm at the cell periphery, in HeLa cells (Fig. 6A, right panel). We observed 
that the mobility of mCherry-UPF1 in the cell periphery was very similar, irrespective of the levels 
of NBAS protein (Fig. 6B; compare si-control, mCherry-UPF1, periphery (in gray) with si-NBAS, 
mCherry-UPF1, periphery (in black). By contrast, a significantly slower mobility of mCherry-
UPF1was observed at the ER in control cells bearing physiological levels of NBAS, as reflected by 
a marked shift of the autocorrelation curve towards longer characteristic times (Fig. 6B, red line). 
Depletion of NBAS increased the mobility of mCherry-UPF1 at the ER (Fig. 6B, blue line), so that 
the diffusion time of mCherry-UPF1 was uniform within the cell. By contrast, the mobility of 
mCherry alone was uniform throughout the cell and was not affected by the level of NBAS expression 
(Supplemental Figs. S8A, B). Fitting of the autocorrelation curves with a two-component diffusion 
model revealed that the characteristic decay time τD2 of mCherry-UPF1 was considerably longer at 
the ER in the presence of NBAS (Fig. 6C, in red), whereas NBAS depletion caused significant 
reduction of the τD2 mCherry-UPF1 decay times (Fig. 6C, in blue). The τD2 decay time of mCherry-
UPF1 was markedly shorter at the cell periphery than at the ER and was not affected by the depletion 
of NBAS (Fig. 6C). The observed reduced mobility of mCherry-UPF1 at the ER strongly suggests 
that UPF1 is part of a slower diffusing protein complex, and that NBAS is required for the retention 
of UPF1 at the ER. In agreement, overexpression of NBAS led to even slower mCherry-UPF1 
mobility at the ER (Fig. 6D; compare wt NBAS level, mCherry-UPF1, ER (in black) with 
overexpressed GFP-NBAS, mCherry-UPF1, ER (in purple)). In accordance, the characteristic decay 
time τD2 of mCherry-UPF1 was significantly increased by the addition of GFP-NBAS (Fig. 6E). These 
results show that ER-localized NBAS acts to recruit UPF1 to the ER to activate a localized NMD 
response (Fig. 7). 
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Discussion 
An NMD response at the ER 
The targeting of mRNAs to specific subcellular sites for local translation has an important role in 
many cellular processes and during development (Decker and Parker 2006). In particular, translation 
of secreted and integral membrane proteins occurs on ER-bound ribosomes, whereas cytosolic protein 
synthesis mostly occurs on ribosomes dispersed throughout the cytoplasm. A subset of transcripts 
that are targeted for translation at the ER encode a leading signal peptide that is recognized after 
emerging from the ribosome by the signal recognition particle (SRP). These SRP-bound transcripts 
are subsequently targeted to the ER, and the resulting translated peptides are translocated across or 
inserted into the membrane by the SEC61 translocation channel (Walter and Johnson 1994). 
However, recent evidence showed that mRNAs encoding cytosolic proteins can also be translated by 
ER-associated ribosomes, suggesting a more diverse role for the ER in mRNA translation 
(Jagannathan et al. 2014b; Reid and Nicchitta 2015).  
 Despite the ER representing a specialized environment for the translation of a large proportion of 
cellular mRNAs, it remains unclear how RNA quality control pathways in general, and NMD in 
particular, operate on those mRNAs. Since NMD is dependent on active translation, transcripts 
coding for secreted and integral membrane proteins will not have sufficient exposure to the NMD 
quality control in the cytoplasm due to the intrinsic nature of ER-associated translation, which is 
spatially and temporally distinct from mRNA translation in the cytosol. In fact, ER-targeted 
transcripts are only translationally active once they encounter the ER membrane (Wu et al. 2016). 
Thus, ER-targeted transcripts will fail to undergo NMD in the cytoplasm, until their translation is 
activated at the ER membrane. We propose that these transcripts are instead targeted for degradation 
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by an ER-NMD dedicated pathway that is responsible for the quality control of cellular mRNAs that 
are translated at the ER.  
 We have previously shown that NBAS together with core NMD factors regulates the stability of a 
large number of endogenous RNA targets that are preferentially linked to cellular stress and 
membrane trafficking in nematodes, zebrafish and human cells (Anastasaki et al. 2011; Longman et 
al. 2013). We also showed that NBAS contributes to a negative feedback regulatory network, in which 
the NMD pathway controls the levels of transcripts encoding NMD factors (Huang et al. 2011; 
Yepiskoposyan et al. 2011; Longman et al. 2013).  Here, we used RNA-sequencing to profile changes 
in mRNA abundance upon depletion of NBAS or UPF1. Importantly, this analysis revealed that a 
large proportion of NBAS regulated targets were co-regulated by UPF1, establishing them as 
candidate NMD targets (Figure 2). These results, together with evidence provided by FCS 
experiments demonstrates that NBAS, which is anchored at the membrane of the ER, promotes the 
recruitment of the core NMD factor UPF1 and thereby activates the NMD response at the ER (Fig. 
6).  The decay step in NMD involves the recruitment of nucleases along two pathways that involve 
endonucleolytic decay mediated by SMG6 (Huntzinger et al. 2008; Eberle et al. 2009), or 
alternatively exonucleolytic decay mediated by the SMG5–SMG7 heterodimer (Loh et al. 2013). 
Interestingly, despite NBAS being preferentially associated with hypophosphorylated UPF1 in the 
SURF complex, we also detected its interaction with SMG5, SMG6 and SMG7 (Supplemental Fig. 
S7), which are required for mRNA degradation at the later stages of NMD. Altogether, this suggests 
that the presence of several core NMD factors is required for an active NMD pathway in the vicinity 
of the ER. In summary, we have identified a localized NMD response at the ER that acts on transcripts 
localized and translated at the ER, which we term ER-NMD (Fig. 7).  
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Biological role of ER-NMD pathway 
Recent evidence supports a role for NMD in modulating the ER stress response by ensuring 
appropriate activation of the Unfolded Protein Response (UPR) (Goetz and Wilkinson 2017). This 
pathway is able to sense and respond to excessive amounts of misfolded proteins in the ER (Walter 
and Ron 2011). Interestingly, mRNAs encoding several UPR components are targeted by NMD, 
including the UPR sensor IRE1α, as well as ATF-4 and CHOP that are activated by PERK branch 
signaling. Thus, NMD can act to control the threshold of cellular stress that is necessary to activate 
the UPR (Gardner 2008; Karam et al. 2015; Sieber et al. 2016). As a consequence, appropriate level 
of NMD activity is required to protect cells from detrimental stress response activation. In particular, 
pathological UPR activation is recognized as a major causal mechanism in neurodegenerative 
diseases including Alzheimer's, Parkinson's and prion diseases, which are associated with the 
accumulation of misfolded disease-specific proteins (Hetz and Mollereau 2014). A chronic activation 
of PERK/eIF2α-P signaling results in a sustained reduction of global protein synthesis rates in 
neurons, caused by the phosphorylation and inactivation of eIF2α, which blocks translation at the 
level of initiation. Inappropriate eIF2α phosphorylation contributes to disease pathogenesis, and is 
observed in patient’s brains, and in mouse models of protein-misfolding neurodegenerative diseases 
(Hoozemans et al. 2009; Moreno et al. 2012). Thus, limiting the chronic activation of the UPR could 
have a neuroprotective effect in neurodegenerative diseases. 
 We hypothesize that modulation of the activity of the ER-NMD pathway could be crucial to 
regulate the response to ER stress. It is tempting to speculate that increasing the activity of the ER-
NMD pathway will have a neuroprotective effect by limiting excessive UPR signalling in 
neurodegeneration. Indeed, a protective role for UPF1 has already been shown in primary neuronal 
models of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) induced by 
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overexpression of the RNA-binding proteins, TDP43 and FUS (Barmada et al. 2015). Moreover, 
NMD has been shown to protect against the effects of hexanucleotide repeat expansion in C9orf72 
(C9-HRE) found in Drosophila and cellular models of ALS/FTD (Ortega et al. 2020; Xu et al. 2019). 
 In summary, we have uncovered a localized NMD response at the ER, which provides spatial and 
temporal separation from cytoplasmic NMD acting on mRNAs that are translated at the ER. This 
could have important implications to protect cells from ER stress/dysfunction that results from the 
accumulation of aberrantly processed RNAs, leading to the production of truncated proteins and 
affecting cellular homeostasis. This could be of particular relevance for many disease processes, such 
as neurodegenerative diseases, where an exacerbated ER stress is observed. Future studies will aim 
to further characterize this novel ER-NMD pathway; investigating its physiological role, as well as 
the biological consequences of manipulating its activity.	
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Material and methods 
NMD reporter assays 
HeLa cells stably expressing HBB wt or HBB NS39 reporters were mock-depleted or depleted twice 
of UPF2, NBAS, STX18 and STX5, and harvested 5 days after the first depletion. Alternatively, 
HeLa HBB NS39/WT expressing cells were treated with 2 µg/ml Actinomycin D (Sigma A9415) to 
block transcription and/or 2µg/ml Brefeldin A (Sigma B5936) to block secretion for 6 h. The stability 
of HBB reporters was determined by qRT-PCR. The fluorescence-based NMD assay was performed 
as described previously (Pereverzev et al. 2015). NMD activity was determined by quantitative 
measurement of red and green fluorescence using FACS BD LSR-Fortessa™ X-20 SORP with BD 
FACSDiva™ software. Gates were set using a non-fluorescent control. Compensation was applied in 
BD FACSDiva™ software using single transfected cells. Green fluorescence expression (488-
525/50) was analyzed by gating the single cell population in SSC-H/SSC-A scatter plot, followed by 
debris-exclusion gate in SSC-A/FSC-A scatter plot, followed by gating only the red fluorescent 
positive cells in 405-450/50 (autofluorescence) and 561-610/20 dot plot. Gate settings were kept 
constant during the experiment. Data was analyzed with FlowJo™ Software (Version 10.6.0). 
Between 4500 and 12000 red fluorescent cells were analyzed in each biological replica. NMD 
disruption was determined by the increase of green fluorescence in red cells, normalized to mock-
depleted cells.    
 
Single-molecule (sm) RNA FISH 
smRNA FISH was performed following the Stellaris RNA FISH protocol for adherent cells 
(www.biosearchtech.com/stellarisprotocols), using RNase-free reagents. Transcript-specific 
Quasar® 570-labeled Stellaris probes were designed with the Stellaris® RNA FISH Probe Designer 
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(Biosearch Technologies, Inc., Petaluma, CA)(www.biosearchtech.com/ stellarisdesigner), and 
resuspended in TE buffer to make 12.5µM Probes stock. Probe sequences are listed on Supplemental 
Table S5. HeLa cells were depleted as described above, with the addition of mEmerald-ER-3 
(Addgene plasmid # 54082; http://n2t.net/addgene:54082; RRID:Addgene 54082) at 1µg per well in 
6-well plates) during the second round of depletions. Cells were seeded on high precision coverslips 
(Marienfeld, #0107052), washed twice with PBS and fixed with 4% formaldehyde at room 
temperature for 10 min. Cells were permeabilized in 70% ethanol for at least 1 hour and hybridization 
of probes was performed in a humidified chamber at 37°C for 15 hours. Probe hybridization and all 
subsequent steps were carried out in the dark. Following hybridization, coverslips were washed as 
described in the protocol. Nuclei were counterstained with 5ng/ml of DAPI in buffer A for 30min. 
Cell outlines were determined by staining with the addition of 20 nM MemBright 640 nm dye (Idylle 
MCO-MEM-640-1902) (Collot et al. 2019) in buffer B for 15 min at room temperature. Coverslips 
were mounted in Vectashield and sealed with nail polish.  
 
Proximity Ligation Assay (PLA) 
PLA assay was performed following Duolink® PLA Fluorescence Protocol (Sigma-Aldrich). Cells 
were grown, fixed and permeabilized as for immunofluorescence. Coverslips were then incubated for 
1 h with PLA block buffer provided with the Duolink in situ PLA probes at room temperature and 
incubated with primary antibodies. Coverslips were then washed 3 times with Duolink wash buffer 
A and Duolink probes incubation, ligation and PLA signal amplification was performed using 
Duolink® In Situ Detection Reagents Red kit according to the manufacturer’s instructions. In the last 
wash coverslips were incubated with DAPI at 50ng/ml in 0.01x wash buffer B for 5 min, mounted in 
Vectrashield and sealed with nail varnish. 
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FRET-FLIM 
HeLa cells transiently expressing GFP-NBAS with mCherry or mCherry-UPF1 were grown on slides 
for 48 h post transfection, fixed in 4% PFA for 10 min, washed in PBS and mounted in Vectashield 
with DAPI to visualize cell nuclei. Fluorescence lifetime images were acquired on a Leica SP5 SMD 
confocal laser-scanning microscope fitted with a time- correlated single photon counting module 
(PicoHarp 300) using a 63/1.4 numeric aperture HCX PL Apo oil immersion objective lens, as 
previously described (Saleeb et al. 2019). The donor EGFP was excited using a tunable white light 
supercontinuum laser operating at 488 nm and pulsing at 40 MHz. Emission was detected with an 
external single- photon avalanche diode (MicroPhoton Devices). Single-pixel fluorescence lifetime 
analyses were carried out with SymPhoTime version 5.4.4 (PicoQuant). 
 
FCS and FCCS 
FCS measurements were performed by recording fluorescence intensity fluctuations in a very small, 
approximately ellipsoidal observation volume element (OVE) (about 0.2 µm wide and 1 µm long) 
that is generated in HeLa cells by focusing the laser light through the microscope objective and by 
collecting the fluorescence light through the same objective using a pinhole in front of the detector to 
block out-of-focus light. The fluorescence intensity fluctuations caused by fluorescently labeled 
molecules passing through the OVE were analyzed using temporal autocorrelation analysis. HeLa 
cells were mock-depleted or depleted of NBAS in two rounds of depletions. During the second round 
of depletions cell were co-transfected with 1 µg of mCherry control or of mCherry-UPF1plasmids. 
For NBAS overexpression, cells were co-transfected with GFP-NBAS and mCherry or mCherry-
UPF1 (1 µg of each). Prior to FCS/FCCS measurement, cells were grown overnight on chambered 
coverslips (μ-slide, 8 well, Ibidi) and the growth medium was replaced with L-15 medium (Leibovitz) 
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(Sigma-Aldrich L1518) immediately prior to FCS/FCCS measurements. Where appropriate, ER was 
visualized by the addition of 1 µM ER Tracker (green) dye (Thermo Fisher, E34251). Measurements 
were made only in weakly expressing cells. Fluorescence microscopy imaging of HeLa cells and FCS 
measurements were performed on a PicoQuant modified Leica SP5 microscope which features 
Avalanche PhotoDiodes that enable close to single-photon detection (Vukojević et al. 2008). 
Fluorescence intensity fluctuations were recorded for 50 sec or 100 sec. Autocorrelation curves were 
analysed using the SymphoTime 64 software package (PicoQuant). Control FCS measurements to 
assess the detection volume were routinely performed prior to data acquisition, using dilute solutions 
(10nM and 20nM, respectively) of Alexa488 and Alexa568 dyes (Petrášek and Schwille 2008). The 
variability between independent measurements reflects the variability between cells, rather than 
imprecision of FCS measurements.   
 
Quantification and Statistical analysis 
For information about the number of replicates, the meaning of error bars (e.g., standard error of the 
mean) and other relevant statistical analysis, see the corresponding figure legend. For information 
about how data was analyzed and/or quantified, see the relevant section in Materials and methods 
and/or the figure legend. GraphPad Prism software was used for the statistical analysis in Figures 1C, 
1D, 3A, 4B, 5C, 6C, 6E, and Supplemental Figs. S1B, S1C, S4, S5A, B.  RStudio was used for the 
statistical analysis in Figures 2A, 2B, 2D, S2 and S3.  
 
Data availability 
All RNA-Seq data will be available at GEO. Accession number being processed. 
The raw uncropped gels, blots and confocal micrographs will be deposited at Mendeley Data. 
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Figure legends 
 
Figure 1. NBAS is an ER-localized protein with dual, independent, functions in NMD and ER 
secretion. (A) Cartoon depicting the functional domains of NBAS and its intracellular localization at 
the Endoplasmic Reticulum (ER), as part of the Syntaxin 18 complex. (B) NMD activity is not 
required for constitutive secretion. Depletion of NMD factors, with the exception of NBAS, does not 
affect the ability of HeLa C1 cells to secrete a GFP-based reporter construct. GFP accumulation was 
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measured by flow cytometry and a secretion defect was defined as a two-fold accumulation of GFP 
reporter (after the addition of 1 µM D/D Solubilizer (ligand) compared to untreated HeLa C1 cells 
(dashed line). Each point represents one biological replica, bars indicate mean with SEM. (C) NMD 
activity is not affected by depletion of secretion factors, STX18 and STX5. In contrast, depletion of 
UPF2 and NBAS led to an upregulation of the HBB NS39 NMD-sensitive reporter. HeLa cells stably 
expressing the HBB NS39 or wild-type (WT) reporters were depleted of the indicated factors and the 
steady state level of the reporter mRNA was measured by qRT-PCR and normalized to POLR2J 
expression. Each point represents one biological replica, bars indicate mean with SEM. Significance 
was determined by two-tailed unpaired t-test: **: p<0.005; *: p<0.05; ns: not significant. (D) NMD 
activity is not affected by blocking constitutive secretion. HeLa cells expressing HBB WT or HBB 
NS39 reporters were treated with Actinomycin D to block transcription and Brefeldin A to block 
constitutive secretion. HBB expression was measured as described in panel (C). Each point represents 
the mean and SEM of three biological replicas. The significance of Brefeldin A treatment was 
determined by two-tailed unpaired t-test: ns: not significant. See Supplemental Fig. S1C for the effect 
of Brefeldin A on secretion.  
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Figure 2.  NBAS-regulated targets are enriched for ER-localized transcripts. (A) Scatter plot of 
differentially expressed transcripts shows a significant positive correlation between NBAS and 
UPF1-regulated targets (Pearson’s correlation r= 0.67; p< 0.0001). Numbers in brackets indicate the 
number of regulated transcripts in each quadrant. (B) NBAS-regulated targets are enriched for 
experimentally identified ER-localized transcripts. Bar charts show the proportion of targets that are 
ER-localized by APEX-seq, ER fractionation and ER proximity-specific ribosome profiling. The ER-
enrichment of NBAS targets is significantly higher than that of UPF1 targets (p< 0.0001, Binomial 
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Exact test), whereas the difference between NBAS targets and NBAS-UPF1 common targets is not 
statistically significant (p= 0.1867, Binomial Exact test).  (C) RNA-seq of samples from subcellular 
fractions (membrane and cytoplasm) allows identification of membrane-associated genes. Scatter plot 
shows average transformed counts of each gene in membrane and cytoplasmic fractions in mock-
depleted cells. (D) NBAS preferentially regulates membrane-associated targets. Plot shows 
percentage of ‘membrane-associated’ genes in the membrane fraction and of ‘non-membrane’ genes 
in the cytoplasm that are regulated (p<0.05) by each NMD factor. NBAS regulates over 5-fold higher 
percentage of membrane-associated genes than non-membrane genes (p<0.001, Exact Binomial test). 
By contrast, UPF1 regulates a similar percentage of both membrane-associated and non-membrane 
genes (1.3-fold higher percentage of membrane-associated genes, p<0.001, Exact Binomial test), and 
UPF2 regulates 2.5-fold higher percentage of non-membrane genes than membrane genes (p<0.001, 
Exact Binomial test).   
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Figure 3. ER-localized NMD targets are degraded at the ER. (A) Relative changes in SETD4 and 
FAP expression upon UPF1 or NBAS depletion were measured by qRT-PCR and normalized to 
POLR2J expression. Each point represents one biological replica, bars indicate mean with SEM. 
Significance was determined by two-tailed unpaired t-test: **: p<0.005; *: p<0.05. (B-C) Single-
molecule (sm) RNA FISH was used to visualize the site of accumulation of a cytoplasmic NMD 
target SETD4 (B), or an ER-localized NMD target FAP (C), within the cell when NMD was abrogated 
by either UPF1 or NBAS knock-down. Individual RNA molecules were visualized by a set of 
transcript-specific Quasar® 570-labelled Stellaris probes and pseudo-colored green. The cell outline 
was visualized by staining with MemBright 640nm probe and is indicated by the yellow line. The ER 
compartment was visualized by mEmeral-ER-3 co-transfected plasmid and is pseudocolored red 
(right column). Each scale bar is 10µm. (D) Distribution of FISH signal within imaged cells is 
represented by the distance of signal from the nucleus in each condition. Graph shows distances as 5-
95 percentile box plots, numbers in brackets indicate the number of analyzed cells. Data was acquired 
in three independent experiments. Statistical significance was determined by one-way ANOVA test. 
****: p_adj<0.0001; ns: not significant.  
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Figure 4. UPF1 localizes at the ER. (A) Immunofluorescence of HeLa cells transiently expressing 
FLAG-tagged UPF1 (in green) together with the ER-marker Calnexin (in red). Cell nuclei were 
visualized by DAPI staining. UPF1 predominantly shows a diffused cytoplasmic localization (top 
panel). Partial cell permeabilization with Digitonin revealed that a fraction of UPF1 is anchored at 
the ER membrane and co-localizes with Calnexin (bottom panel). (B) UPF1 is localized in the close 
proximity of the SEC61B translocon component at the ER. Proximity Ligation Assay (PLA) using 
antibodies against endogenous UPF1 and SEC61B proteins generated a discrete signal (red spots), 
indicating that the proteins are less than 40nm apart. The graph shows the quantification of PLA 
signal. Each point represents mean PLA count per cell in one captured frame. Significance was 
determined by two-tailed Mann-Whitney test: **: p<0.005. Data showing the co-localization of 
NBAS and UPF2 with SEC61B can be found in Supplemental Fig. S5. 
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Figure 5. NBAS and UPF1 interact directly. (A) The interaction between NBAS and UPF1 was 
measured by FRET-FLIM. The average fluorescence lifetime of GFP-NBAS donor molecules was 
measured in HeLa cells expressing GFP-tagged NBAS together with mCherry-UPF1 or mCherry, as 
a control. Cells were pseudo-colored by average lifetime (ns) where red represents longer lifetime 
and green corresponds to a shorter lifetime. Average fluorescence lifetime was used to calculate the 
FRET efficiency (right panel). Cells were pseudo-colored by FRET efficiency (%). (B) The 
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interaction between NBAS and UPF1 was measured by Fluorescence Cross-Correlation Spectroscopy 
(FCCS) in HeLa cells transiently expressing GFP-NBAS and mCherry-UPF1 or GFP-NBAS and 
mCherry, as a control. Increased G(τ) amplitude of the average cross-correlation curves corresponds 
to higher cross-correlation (higher fraction of co-diffusing molecules) of GFP-NBAS and mCherry-
UPF1 (in black), as compared to GFP-NBAS and mCherry average cross-correlation (in grey). (C) A 
direct interaction between endogenous NBAS and UPF1 was determined by PLA using antibodies 
against endogenous UPF1 and NBAS proteins in HeLa cells. The PLA signal in wild-type (wt) HeLa 
cells was compared to a HeLa NBAS knock-out (KO) cells, as a negative control. The PLA signal 
was quantified in the graph where each point represents mean PLA count in one captured frame, 
relative to NBAS KO negative control. Significance was determined by two-tailed Mann-Whitney 
test: ****: p<0.0001.  
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Figure 6. NBAS recruits UPF1 to the ER. (A) Schematic representation of the principle of 
Fluorescence Correlation Spectroscopy (FCS). See text in methods section for details. (B) Average 
autocorrelation curves of mCherry-UPF1 at the ER or cell periphery in the presence (si-control) or 
absence of NBAS (si-NBAS) are displayed. (C) Graph showing the derived characteristic decay times 
τD2 (slow FCS component) of mCherry-UPF1, after fitting of the autocorrelation curves with a two-
component model for diffusion (plus triplet correction). Significance was determined by the two-
tailed Mann-Whitney test: ****: p<0.0001; ***: p<0.001; ns: not significant. (D) Average 
autocorrelation curves of mCherry-UPF1 at the ER with physiological (wt) or increased (GFP-NBAS) 
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level of NBAS expression. (E) Characteristic decay times τD2 (slow FCS component), derived as in 
(C) of mCherry-UPF1 at the ER. Significance was determined by the two-tailed Mann-Whitney test: 
****: p<0.0001. Data showing FCS control experiments can be found in Supplemental Fig. S8. 
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Figure 7. Model for an ER-NMD pathway. NBAS is an NMD factor that localizes to the membrane 
of the endoplasmic reticulum (ER). NBAS recruits the core NMD factor UPF1 and tethers it to the 
membrane of the ER to activate a local NMD response that targets for degradation mRNAs that are 
translated at the ER. 
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